Although representing an undeniable step forward in developing an in vitro model of vascular AD, this model requires the overexpression of APP/PSEN1 genes with early onset familial AD (FAD) mutations due to short culture times, which may limit the physiologic relevance of the model to study late onset AD that accounts for the majority of total AD cases [45]. Here, PSEN1 is linked to familial Alzheimer disease.